High early event rates in patients with questionable eligibility for advanced heart failure therapies: Results from the Medical Arm of Mechanically Assisted Circulatory Support (Medamacs) Registry
- 1 June 2016
- journal article
- research article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 35 (6) , 722-730
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure PatientsJACC, 2015
- Crisis Awaiting Heart TransplantationJAMA Internal Medicine, 2015
- Change in health-related quality of life from before to after destination therapy mechanical circulatory support is similar for older and younger patients: Analyses from INTERMACSThe Journal of Heart and Lung Transplantation, 2015
- Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for heart transplantationAmerican Heart Journal, 2014
- Sixth INTERMACS annual report: A 10,000-patient databaseThe Journal of Heart and Lung Transplantation, 2014
- Frailty and outcomes after implantation of left ventricular assist device as destination therapyThe Journal of Heart and Lung Transplantation, 2014
- Risk Score Model for Predicting Mortality in Advanced Heart Failure Patients Followed in a Heart Failure ClinicCongestive Heart Failure, 2012
- Addition of Frailty and Disability to Cardiac Surgery Risk Scores Identifies Elderly Patients at High Risk of Mortality or Major MorbidityCirculation: Cardiovascular Quality and Outcomes, 2012
- Frailty and the Selection of Patients for Destination Therapy Left Ventricular Assist DeviceCirculation: Heart Failure, 2012
- Frailty in Older Adults: Evidence for a PhenotypeThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2001